GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Price-to-Tangible-Book

Qyuns Therapeutics Co (HKSE:02509) Price-to-Tangible-Book : 11.45 (As of May. 29, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Price-to-Tangible-Book?

As of today (2025-05-29), Qyuns Therapeutics Co's share price is HK$11.32. Qyuns Therapeutics Co's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was HK$0.99. Hence, Qyuns Therapeutics Co's Price to Tangible Book Ratio of today is 11.45.

The historical rank and industry rank for Qyuns Therapeutics Co's Price-to-Tangible-Book or its related term are showing as below:

HKSE:02509' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.46   Med: 7.46   Max: 11.63
Current: 11.43

During the past 4 years, Qyuns Therapeutics Co's highest Price to Tangible Book Ratio was 11.63. The lowest was 7.46. And the median was 7.46.

HKSE:02509's Price-to-Tangible-Book is ranked worse than
86.8% of 1197 companies
in the Biotechnology industry
Industry Median: 2.75 vs HKSE:02509: 11.43

A closely related ratio is called PB Ratio. As of today, Qyuns Therapeutics Co's share price is HK$11.32. Qyuns Therapeutics Co's Book Value per Sharefor the quarter that ended in Dec. 2024 was HK$1.10. Hence, Qyuns Therapeutics Co's P/B Ratio of today is 10.28.


Qyuns Therapeutics Co Price-to-Tangible-Book Historical Data

The historical data trend for Qyuns Therapeutics Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Price-to-Tangible-Book Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
- - - 7.46

Qyuns Therapeutics Co Quarterly Data
Dec21 Dec22 Sep23 Dec23 Jun24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial - - - 10.38 7.46

Competitive Comparison of Qyuns Therapeutics Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Qyuns Therapeutics Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qyuns Therapeutics Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Qyuns Therapeutics Co's Price-to-Tangible-Book falls into.


;
;

Qyuns Therapeutics Co Price-to-Tangible-Book Calculation

Qyuns Therapeutics Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=11.32/0.989
=11.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Qyuns Therapeutics Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Qyuns Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Executives
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Jian Xin Chuang Ye Tou Zi You Xian Gong Si 2101 Beneficial owner
Hang Zhou Zhong Mei Hua Dong Zhi Yao You Xian Gong Si 2101 Beneficial owner
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Yuan Da Hua Chuang Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Hua Dong Yi Yao Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Qiu Jiwan
Xu Qiu
Hangzhou Quanyi Investment Management Partnership (general Partnership)
Yu Guo'an
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Sheng Xi Tai

Qyuns Therapeutics Co Headlines

No Headlines